AURA BIOSCIENCES INC (AURA) Stock News

USA - Nasdaq - NASDAQ:AURA - US05153U1079 - Common Stock

6.43 USD

-0.02 (-0.31%)

Last: 12/5/2025, 8:03:55 PM

6.43 USD

0 (0%)

After Hours: 12/5/2025, 8:03:55 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AURA Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Aura Biosciences, Inc.

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

24 days ago - By: Aura Biosciences, Inc.

Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights

3 months ago - By: Aura Biosciences, Inc.

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

4 months ago - By: The Motley Fool

Aura Biosciences Posts Q2 Cash Surge

4 months ago - By: Aura Biosciences, Inc.

Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights

a year ago - By: Benzinga

Aura Biosciences Touts Promising Data From Eye Cancer Candidate

4 months ago - By: The Motley Fool - Mentions: AMZN META NVDA AUR ...

4 Artificial Intelligence Stocks (That Aren't Nvidia) You Can Buy and Hold for the Next Decade

7 months ago - By: Aura Biosciences, Inc.

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

7 months ago - By: Aura Biosciences, Inc.

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants

7 months ago - By: Aura Biosciences, Inc.

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

7 months ago - By: Aura Biosciences, Inc.

Aura Biosciences to Participate in Upcoming Investor Conferences

8 months ago - By: Benzinga - Mentions: STBX LRHC ASML BLMZ ...

Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

a year ago - By: BusinessInsider

News Image

AURA Stock Earnings: Aura Biosciences Beats EPS for Q2 2024

a year ago - By: InvestorPlace

AURA Stock Earnings: Aura Biosciences Beats EPS for Q2 2024

8 months ago - By: Yahoo Finance

Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?

8 months ago - By: Aura Biosciences, Inc.

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

9 months ago - By: Aura Biosciences, Inc.

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

9 months ago - By: Aura Biosciences, Inc.

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

9 months ago - By: Aura Biosciences, Inc.

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

9 months ago - By: Aura Biosciences, Inc.

Aura Biosciences to Participate in Upcoming Investor Conferences

a year ago - By: Aura Biosciences, Inc.

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial

a year ago - By: Aura Biosciences, Inc.

Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma

a year ago - By: Aura Biosciences, Inc.

Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024

a year ago - By: Aura Biosciences, Inc.

Aura Biosciences to Participate in Upcoming Investor Conferences

a year ago - By: Aura Biosciences, Inc.

Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting

a year ago - By: Aura Biosciences, Inc.

Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights

2 years ago - By: Aura Biosciences, Inc.

Aura Biosciences to Participate in the Jefferies Global Healthcare Conference

2 years ago - By: Aura Biosciences, Inc.

Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024